Clay enriched silk biomaterials for bone formation
Source abstract
Abstract
The formation of silk protein/clay composite biomaterials for bone tissue formation is described. Silk fibroin serves as an organic scaffolding material offering mechanical stability suitable for bone-specific uses. Clay montmorillonite (Cloisite® Na(+)) and sodium silicate are sources of osteoinductive silica-rich inorganic species, analogous to bioactive bioglass-like bone repair biomaterial systems. Different clay particle-silk composite biomaterial films were compared with silk films doped with sodium silicate as controls for the support of human bone marrow derived mesenchymal stem cells in osteogenic culture. The cells adhered to and proliferated on the silk/clay composites over 2 weeks. Quantitative real time polymerase chain reaction analysis revealed increased transcript levels for alkaline phosphatase, bone sialoprotein, and collagen type 1 osteogenic markers in the cells cultured on the silk/clay films in comparison with the controls. Early evidence of bone formation based on collagen deposition at the cell-biomaterial interface was also found, with more collagen observed for the silk films with higher contents of clay particles. The data suggest that silk/clay composite systems may be useful for further study for bone regenerative needs.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Silk-based biomaterials and applications · Bone Tissue Engineering Materials · Collagen: Extraction and Characterization
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (48)
Show source-provided references
1. Novel bioactive materials with different mechanical properties10.1016/S0142-9612(03)00044-9 ↗
2. In vitro osteogenic differentiation of rat bone marrow cells subcultured with and without dexamethasone10.1089/107632702753725076 ↗
3. Functional biomaterials: design of novel biomaterials10.1146/annurev.matsci.31.1.183 ↗
4. New opportunities for an ancient material10.1126/science.1188936 ↗
5. Silk fibroin microtubes for blood vessel engineering10.1016/j.biomaterials.2007.08.008 ↗
6. Physico-chemical properties of silk fibroin membrane as a biomaterial10.1016/0142-9612(90)90100-5 ↗
7. Silk-based materials for biomedical applications10.1042/BA20090229 ↗
8. Water-stable silk films with reduced β-sheet content10.1002/adfm.200400405 ↗
9. Controlling beta-sheet assembly in genetically engineered silk by enzymatic phosphorylation/dephosphorylation10.1021/bi001335w ↗
10. Correlation of the β-sheet crystal size in silk fibers with the protein amino acid sequence10.1039/B701220A ↗
11. New process to form a silk fibroin porous 3-D structure10.1021/bm050431f ↗
12. Electrospinning Bombyx mori silk with poly(ethylene oxide)10.1021/bm025581u ↗
13. Structure and properties of silk hydrogels10.1021/bm0345460 ↗
14. Controlled release of donepezil intercalated in smectite clays10.1016/j.ijpharm.2008.04.012 ↗
15. Polymer-layered silicate nanocomposites: preparation, properties and uses of a new class of materials10.1016/S0927-796X(00)00012-7 ↗
16. Relationship of swelling and swelling pressure on silica–water interactions in montmorillonite10.1021/la051533u ↗
17. Nanoclays for polymer nanocomposites, paints, inks, greases and cosmetics formulations, drug delivery vehicle and waste water treatment10.1007/BF02704606 ↗
18. Development of new polyolefin films with nanoclays for application in food packaging10.1016/j.eurpolymj.2007.01.021 ↗
19. Matrix-immobilized organoclay for the sorption of polycyclic aromatic hydrocarbons and pentachlorophenol from groundwater10.1016/j.chemosphere.2004.12.022 ↗
20. Removal of mercury species with dithiocarbamate-anchored polymer/organosmectite composıtes10.1016/j.jhazmat.2007.03.089 ↗
21. Polymer-layered silicate nanocomposites: an overview10.1016/S0169-1317(99)00017-4 ↗
22. Polymer-layered silicate nanocomposites: synthesis, properties and applications10.1002/(SICI)1099-0739(199810/11)12:10/11<675::AID-AOC779>3.0.CO;2-V ↗
23. Synthesis and characterization of nylon l0l2/clay nanocomposites10.1002/app.10198 ↗
24. Mechanical properties of sodium montmorillonite interlayer intercalated with amino acids10.1021/bm0503219 ↗
25. Insight into molecular interactions between constituents in polymer clay nanocomposites10.1016/j.polymer.2006.05.026 ↗
26. Drug release behavior of chitosan–montmorillonite nanocomposite hydrogels following electrostimulation10.1016/j.actbio.2008.01.012 ↗
27. Poly(ethylene glycol) layered silicate nanocomposites for retarded drug release prepared by hot-melt extrusion10.1016/j.ijpharm.2008.06.027 ↗
28. Modified montmorillonite as vector for gene delivery10.1016/j.biomaterials.2005.12.029 ↗
29. Cell proliferation and controlled drug release studies of nanohybrids based on chitosan–g-lactic acid and montmorillonite10.1016/j.actbio.2008.08.007 ↗
30. Use of unnatural amino acids for design of novel organomodified clays as components of nanocomposite biomaterials10.1098/rsta.2010.0008 ↗
31. PMMA-grafted nanoclay as novel filler for dental adhesives10.1016/j.dental.2008.08.005 ↗
32. A novel method to prepare chitosan/montmorillonite nanocomposites10.1002/app.22401 ↗
33. In vitro biodegradation and biocompatibility of gelatin/montmorillonite–chitosan intercalated nanocomposite10.1007/s10856-006-0093-y ↗
34. In vitro fibroblast response to polyurethane organosilicate nanocomposites10.1002/jbm.a.31667 ↗
35. The effect of organo clay and adsorbed FeO(3) nanoparticles on cells cultured on ethylene vinyl acetate substrates and fibers10.1016/j.biomaterials.2008.09.015 ↗
36. Synthesis and characterization of a novel chitosan/montmorillonite/hydroxyapatite nanocomposite for bone tissue engineering10.1088/1748-6041/3/3/034122 ↗
37. Preparation, characterization and in vitro biological study of biomimetic three-dimensional gelatin–montmorillonite/cellulose scaffold for tissue engineering10.1007/s10856-009-3818-x ↗
38. Osteoinductive silk–silica composite biomaterials for bone regeneration10.1016/j.biomaterials.2010.07.109 ↗
39. Micropatterned surfaces for control of cell shape, position, and function10.1021/bp980031m ↗
40. Microarray-based gene expression analysis of human osteoblasts in response to different biomaterials10.1002/jbm.a.31701 ↗
41. Genotoxicity of poorly soluble particles10.1080/08958370701496202 ↗
42. Genotoxicity of unmodified and organo-modified montmorillonite10.1016/j.mrgentox.2010.04.021 ↗
43. Cytotoxic effects induced by unmodified and organically modified nanoclays in the human hepatic HepG2 cell line10.1002/jat.1564 ↗
44. Characterization of human fetal osteoblasts by microarray analysis following stimulation with 58S bioactive gel–glass ionic dissolution products10.1002/jbm.b.30455 ↗
45. Enhanced osteocalcin expression by osteoblast-like cells (MC3T3-E1) exposed to bioactive coating glass (SiO2–CaO–P2O5–MgO–K2O–Na2O system) ions10.1016/j.actbio.2009.05.035 ↗
46. Bone development and its relation to fracture repair. The role of mesenchymal osteoblasts and surface osteoblasts10.22203/eCM.v015a05 ↗
47. Collagen–silica hybrid materials: sodium silicate and sodium chloride effects on type I collagen fibrillogenesis
48. Comparative study of the influence of several silica precursors on collagen self-assembly and of collagen on ‘Si’ speciation and condensation10.1039/B606270A ↗